Terumo (4543.T) Financial Analysis & Valuation | Quarter Chart
Terumo (4543.T)
4543.TPrice: $15.08
Fair Value: 🔒
🔒score
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angi... more
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. ... more
Description
Shares
| Market Cap | $22.25B | Exchange | JPX |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | JP | CEO | Hikaru Samejima |
| IPO Date | 2000-01-04 | CAGR | 0.08% |
| Employees | 30,207 | Website | www.terumo.co.jp |
| Div. Yield | 1.2% | Payout Ratio | 0.3% |
| Buy Back Yield | — | Total Yield | 1.2% |
4543.T chart loading...
Fundamentals
Technicals
| Enterprise Value | $3209.37B | P/E Ratio | 26.03 |
| Forward P/E | — | PEG Ratio | 0.6 |
| P/S Ratio | 3.27 | P/B Ratio | 2.34 |
| P/CF Ratio | 16.05 | P/FCF Ratio | 25.44 |
| EPS | $0.58 | EPS Growth 1Y | 16.67% |
| EPS Growth 3Y | 6.89% | EPS Growth 5Y | -9.8% |
| Revenue Growth 1Y | 9.24% | Gross Margin | 0.53% |
| Operating Margin | 0.16% | Profit Margin | 0.12% |
| ROE | 0.09% | ROA | 0.06% |
| ROCE | 0.1% | Current Ratio | 1.59 |
| Quick Ratio | 0.97 | Cash Ratio | 0.52 |
| Debt/Equity | 0.24 | Interest Coverage | 56.22 |
| Altman Z Score | 4.44 | Piotroski Score | 6 |